PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment. (pnas.org)

Authors: Fang S … Dong Z Journal: PNAS Published: 2026-03-31 DOI: https://doi.org/10.1073/pnas.2525213123